A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives
about
Combined oral contraceptives: venous thrombosisDifferent combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysisThird generation oral contraceptives and risk of venous thrombosis: meta-analysisPitfalls of pharmacoepidemiologyRisk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.Hormonal contraception and thrombotic risk: a multidisciplinary approach.Ethynilestradiol 20 mcg plus Levonorgestrel 100 mcg: Clinical PharmacologyBritish Thoracic Society guidelines for the management of suspected acute pulmonary embolismUse of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databasesVenous thromboembolism in patients with membranous nephropathyValidation of the diagnosis of venous thromboembolism in general practice database studiesComparative study of the effects of combined oral contraceptives in hemostatic variables: an observational preliminary study.Combined hormonal contraception and venous thromboembolism.Factor V leiden thrombophilia in a female collegiate soccer athlete: a case report.The Prophylaxis of Venous Thromboembolism.Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis.Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databasesEstrogen-free oral hormonal contraception: benefits of the progestin-only pill.Estrogen and thrombosis: controversies and common sense.Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.Drug safety evaluation of desogestrel.The synthetic progestin, gestodene, affects functional biomarkers in neonatal rat osteoblasts through an estrogen receptor-related mechanism of action.Oral contraceptives, hormone therapy and cardiovascular risk.A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome.
P2860
Q24198113-CBE520B3-E64A-4A49-8511-40436449D09EQ24624180-A37C1939-45DA-427C-941A-723FB2690AE9Q28344562-F8606FD1-1E83-4ED7-9571-0EAFC8985F1AQ33803070-70E4615B-DDD1-4D9F-8F87-FF5DC5D5B23CQ33879375-5DF7E7BA-2D10-4550-B80F-A8737D5B89AFQ34513007-016BD57C-55F7-4453-A0EC-956E64AB34F4Q34588375-CE0F43A7-C50B-4059-9CBF-6F9CCEE87EB4Q35535961-8BE62F8F-D8E5-4967-8765-D74D2336056EQ35651010-F4B7C926-BDEC-4839-AA15-F74A8D7FDD25Q35692422-FE790061-31CD-4DF5-9CC7-E49E8596B80FQ36055463-C5E089BE-9BE1-4F1B-BFDB-B5BB029DB75DQ36153437-EE3BD619-69DD-409A-B4D6-B7E06C416A78Q36845040-19644E79-196B-4D05-827A-96555341E361Q36849098-0E126976-48D1-4A5E-97A7-B3A9BFB7ED2CQ37233818-C7FD6FD0-41AE-4966-802C-E08BB9EDAA54Q37351686-90A4883F-1CF9-434B-9DA3-17E2CC647EACQ37363738-0DBE30DF-E699-4A83-8868-B0945E2B48EDQ37704438-4070B2E4-5537-488E-BCD1-EE939A515BB2Q37809855-618C895B-C4AE-4AA1-B016-3DF1D0AD8804Q37874154-91D7CCCC-10D0-488F-8A44-0353535F97EFQ37975229-ADA4EFB8-DA2A-467E-8052-29D03C9BEEA7Q37979258-6B665CBE-3621-42FD-862E-554010AA331BQ38096431-1F50DF80-9411-4437-B096-41D9CDFA806FQ38887127-BA840235-A9D7-4C3E-8852-115EF5ACEB86Q42596905-478FBD2F-64E1-462E-BBC8-1B9FC891A0E8Q48517068-C2BAB41F-6DE4-4305-A580-5B62F10CA0F9Q50744133-54F320A4-BC96-4EDC-88D0-6AB43F47691A
P2860
A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
A comparison of the risks of v ...... t combined oral contraceptives
@ast
A comparison of the risks of v ...... t combined oral contraceptives
@en
type
label
A comparison of the risks of v ...... t combined oral contraceptives
@ast
A comparison of the risks of v ...... t combined oral contraceptives
@en
prefLabel
A comparison of the risks of v ...... t combined oral contraceptives
@ast
A comparison of the risks of v ...... t combined oral contraceptives
@en
P2093
P2860
P1476
A comparison of the risks of v ...... t combined oral contraceptives
@en
P2093
K D MacRae
R A Lawrenson
R D Farmer
T J Williams
P2860
P304
P356
10.1046/J.1365-2125.2000.00198.X
P407
P577
2000-06-01T00:00:00Z